Telix Pharmaceuticals Ltd
Company Profile
Business description
Telix Pharmaceuticals Ltd is a clinical-stage biotechnology company engaged in developing and commercializing molecularly-targeted radiation therapy to address the unmet needs in the management of prostate, renal (kidney), and glioblastoma (brain) cancer. Geographically, It operates through two reportable segments Commercial operations which include Commercial sales of Illuccix® and other products after obtaining regulatory approvals and Product development includes Developing radiopharmaceutical products for commercialisation. This segment includes revenue received from license agreements before commercialization and research and development services. It operates in Australia, the United States, Belgium, and Japan.
Contact
55 Flemington Road
Suite 401, North Melbourne
Melbourne VIC 3051
AUST: +61 449148448
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
234
Stocks News & Analysis
stocks
The best US tech shares to buy
video
Why Siteminder is like Shopify for hotels
stocks
We think this beaten up ASX share has fallen too far
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,206.10 | 72.70 | 0.89% |
| CAC 40 | 7,724.32 | 97.19 | 1.27% |
| DAX 40 | 18,748.18 | 213.62 | 1.15% |
| Dow JONES (US) | 40,000.90 | 247.15 | 0.62% |
| FTSE 100 | 8,252.91 | 29.57 | 0.36% |
| HKSE | 18,293.38 | 461.05 | 2.59% |
| NASDAQ | 18,398.45 | 115.04 | 0.63% |
| Nikkei 225 | 41,190.68 | 1,033.34 | -2.45% |
| NZX 50 Index | 12,134.97 | 76.68 | 0.64% |
| S&P 500 | 5,615.35 | 30.81 | 0.55% |
| S&P/ASX 200 | 7,959.30 | 69.70 | 0.88% |
| SSE Composite Index | 2,971.29 | 0.91 | 0.03% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Sayona Mining Ltd SYA | 0.03 | 0.00 | 3.03% |
| Core Lithium Ltd CXO | 0.11 | 0.01 | 10.00% |
| Red 5 Ltd RED | 0.43 | 0.01 | 1.19% |
| Imugene Ltd IMU | 0.06 | 0.01 | 9.26% |
| Telstra Group Ltd TLS | 3.82 | 0.00 | 0.00% |
| Droneshield Ltd DRO | 2.34 | 0.16 | 7.34% |
| Mirvac Group MGR | 2.01 | 0.08 | 4.15% |
| Latin Resources Ltd LRS | 0.17 | 0.00 | 0.00% |
| Melbana Energy Ltd MAY | 0.02 | 0.00 | -4.35% |
| Botanix Pharmaceuticals Ltd BOT | 0.38 | 0.06 | 16.92% |